Literature DB >> 9344636

Effect of amiloride A Na+/H+ exchange inhibitor on cardioprotective effect of ischaemic preconditioning: possible involvement of resident cardiac mast cells.

H Kaur1, V Parikh, A Sharma, M Singh.   

Abstract

The present study was designed to investigate the effect of amiloride, a Na+/H+ exchange inhibitor on cardioprotective effect of ischaemic preconditioning in isolated rat heart. Four episodes of ischaemic preconditioning and amiloride (174 microM) treatment markedly decreased the release of lactate dehydrogenase (LDH) and creatine kinase (CK) in coronary effluent and infarct size in hearts subjected to 30 min of global ischaemia followed by 120 min of reperfusion. Amiloride (174 microM) administered during ischaemic preconditioning (Amiloride in Ischaemic Preconditioning), produced no marked effect on LDH and CK release and infarct size. Ischaemic preconditioning and amiloride treatment significantly reduced ischaemia/reperfusion induced release of mast cell peroxidase (MPO). Four episodes of pH (20 mm of ammonium chloride) preconditioning also produced cardioprotection and decreased ischaemia/reperfusion induced release of MPO. It is interesting to note that a significant increase in release of MPO was observed immediately after ischaemic preconditioning and the release was inhibited by amiloride. Moreover, similar increase in MPO release was noted immediately after pH preconditioning. These findings tentatively suggest that ischaemic preconditioning and pH preconditioning produced cardioprotective effect by activating Na+/H+ exchange and consequent degranulation of resident cardiac mast cells. Amiloride administered during ischaemic preconditioning attenuated the cardioprotective effect of ischaemic preconditioning. Copyright 1997 The Italian Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344636     DOI: 10.1006/phrs.1997.0174

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.

Authors:  V Parikh; M Singh
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

Review 2.  Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Authors:  Ioanna Andreadou; Hector A Cabrera-Fuentes; Yvan Devaux; Nikolaos G Frangogiannis; Stefan Frantz; Tomasz Guzik; Elisa A Liehn; Clarissa P C Gomes; Rainer Schulz; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

3.  Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.

Authors:  Lalita Babbar; Nanjaian Mahadevan; Pitchai Balakumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-17       Impact factor: 3.000

4.  Effects of ischemic preconditioning on myocardium Caspase-3, SOCS-1, SOCS-3, TNF-α and IL-6 mRNA expression levels in myocardium IR rats.

Authors:  Jiangwei Ma; Zengyong Qiao; Biao Xu
Journal:  Mol Biol Rep       Date:  2013-10-05       Impact factor: 2.316

5.  Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart.

Authors:  Ankur Rohilla; M U Khan; Razia Khanam
Journal:  J Adv Pharm Technol Res       Date:  2012-07

6.  Protective role of fibrates in cardiac ischemia/reperfusion.

Authors:  G S Sugga; M U Khan; R Khanam
Journal:  J Adv Pharm Technol Res       Date:  2012-07

7.  The effect of Allium sativum on ischemic preconditioning and ischemia reperfusion induced cardiac injury.

Authors:  Rajbir Bhatti; Kushlinder Singh; M P S Ishar; Jatinder Singh
Journal:  Indian J Pharmacol       Date:  2008-11       Impact factor: 1.200

8.  Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart.

Authors:  Preeti Ajmani; Harlokesh N Yadav; Manjeet Singh; Pyare L Sharma
Journal:  BMC Cardiovasc Disord       Date:  2011-07-12       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.